Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Change in Cash (2016 - 2026)

Cartesian Therapeutics (RNAC) has disclosed Change in Cash for 12 consecutive years, with -$6.5 million as the latest value for Q1 2026.

  • For Q1 2026, Change in Cash rose 79.8% year-over-year to -$6.5 million; the TTM value through Mar 2026 reached -$61.7 million, down 179.85%, while the annual FY2025 figure was -$87.4 million, 164.27% down from the prior year.
  • Change in Cash hit -$6.5 million in Q1 2026 for Cartesian Therapeutics, up from -$18.2 million in the prior quarter.
  • Across five years, Change in Cash topped out at $132.0 million in Q3 2024 and bottomed at -$34.0 million in Q3 2023.
  • Average Change in Cash over 5 years is $290588.2, with a median of -$6.6 million recorded in 2024.
  • On a YoY basis, Change in Cash climbed as much as 7098.83% in 2022 and fell as far as 989.29% in 2022.
  • Cartesian Therapeutics' Change in Cash stood at -$6.4 million in 2022, then soared by 57.97% to -$2.7 million in 2023, then plummeted by 144.73% to -$6.6 million in 2024, then plummeted by 176.94% to -$18.2 million in 2025, then skyrocketed by 64.38% to -$6.5 million in 2026.
  • According to Business Quant data, Change in Cash over the past three periods came in at -$6.5 million, -$18.2 million, and -$16.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.